Micro RNAs as Biomarkers of Bariatric Surgery Outcome and Putative Regulators of Hepatokines Selectively after Gastric Bypass, but not Sleeve Gastrectomy
Journal Title: Journal of Obesity and Bariatrics - Year 2016, Vol 3, Issue 1
Abstract
The obesity prevalence is increasing worldwide, resulting in more bariatric surgeries interventions being performed. However, the success of surgical approaches in treating obesity and its co-morbidities varies between types of surgery and is not readily explained by baseline clinical features. Better understanding is needed of the metabolic shifts, and their underpinning mechanisms, which result from different types of surgery. We investigated effects of bariatric surgery on miRNA profile before and after of either gastric bypass surgery (GBP) or sleeve gastrectomy (SG) in nine obese patients with type 2 diabetes mellitus (T2DM). Recent work has identified early reduction in post-operative circulating levels of the hepatokine fetuin-A (FetA) after GBP but not SG, as a putative candidate to monitor the intervention efficacy. Therefore, we used FFA-induced HepG2 cells to indicate the underlying mechanism these miRNAs could lead to increased FetA level. Here we defined a specific set of miRNA species whose postsurgery expression among GBP patients correlated strongly with beneficial decreases in body mass index (BMI) and blood glucose (HbA1c) levels. Additionally, we reported that expression of both FetA and leukocyte cell-derived chemotaxin2 (LECT2; another major hepatokine) was dependent on intracellular signaling by metabolic regulator myostatin (MSTN). Finally, we linked the miR-335 activity in particular to FFA-induced, MSTN-dependent regulation of FetA. These data provide novel mechanistic insights into the metabolic stimulation of hepatokine expression, and the epigenetics role in mediating hepatocellular changes associated with greater weight loss and diabetes remission observed with GBP rather than SG.
Authors and Affiliations
Allan M Sheppard
Keywords
Related Articles
- EP ID EP205484
- DOI 10.13188/2377-9284.1000018
- Views 111
- Downloads 0
Revisional Bariatric Surgery
Background: To elucidate percent excess body weight loss (%EBWL) gained from revisional surgery and to determine resolution of comorbid conditions given the obesity epidemic.Methods: All patients undergoing revisional ba...
Why do Patients who Underwent Laparoscopic Adjustable Gastric Banding Surgery, Decide to Remove their Band, a Retrospective Cohort Study
Background: Obesity is becoming more and more prevalent in western society. It is estimated that obesity will become a serious burden to society in the next century. Surgery has been shown to be the most effective method...
Portomesentric Vein Thrombosis: Our Experience of 3527 Laparoscopic Bariatric Surgery Procedures in Qatar
Background: Portomesentric vein thrombosis (PMVT) is a rare but potentially serious and life threatening complication that may happen following laparoscopic bariatric surgery (LBS). Multifactorial local and systemic prot...
Bariatric Procedures Unmasking Celiac Disease
Celiac disease is being recognized more frequently but often remains undiagnosed. Celiac disease patients are increasingly obese. Major operation in patients with celiac disease may cause symptoms which lead to the diagn...
Signs of Depression Following Laparoscopic Gastric Banding
Background: Long-term outcomes of laparoscopic gastric banding (LGB) related to depression and predictors of changes in depression are still unclear. Our goal was to investigate signs of depression after LGB. Methods: T...